** Shares of medical device maker ResMed RMD.N down 4.3% at $221.44
** Stifel cuts PT to $240 from $250, reiterates "hold" rating
** Eleven brokerages rate company "buy" or higher, while six "hold" and one "strong sell"; median PT at $278.66 - LSEG data
** Including session's move, stock down 3.1% YTD
(Reporting by Jaiveer Singh Shekhawat in Bengaluru)
((JaiveerSingh.Shekhawat@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。